Clinitech Laboratory Ltd

BSE: 544220

₹40.40

up-down-arrow1.90 (4.94%)

As on 21-May-2026IST

Market cap

info icon

₹9 Cr

Revenue (TTM)

info icon

₹8 Cr

P/E Ratio

info icon

23.4

P/B Ratio

info icon

1

Div. Yield

info icon

0 %

Clinitech Laboratory Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 40.40 High: 40.40

52 Week Range

Low: 28.55 High: 57.00

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹0 Cr

  • ROEROE information

    6.4 %

  • ROCEROCE information

    9.2 %

  • Industry P/EIndustry P/E information

    56.08

  • EV/EBITDAEV/EBITDA information

    5.8

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹38.7

  • EPSEPS information

    ₹1.7

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    2,282,400

5 Years Aggregate

CFO

₹0.42 Cr

EBITDA

₹5.09 Cr

Net Profit

₹2.29 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Clinitech Laboratory
-4.0 -11.2 -8.2 -5.4 -- -- --
BSE Healthcare*
9.3 8.8 6.8 11.3 26.4 14.0 12.1
As on 21-May-2026  |  *As on 27-May-2026
Company
2025
Clinitech Laboratory
-46.6
BSE Small Cap
-6.6
BSE Healthcare
-3.3

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Clinitech Laboratory
40.4 9.2 8.2 0.4 -- 6.4 23.4 1.0
1,617.2 27,125.5 2,762.9 509.8 22.5 21.5 53.7 10.8
784.5 31,398.9 3,904.6 239.4 13.3 11.1 130.1 14.0
538.5 1,749.1 772.8 101.5 15.7 10.7 17.2 1.8
536.2 11,144.1 1,645.9 191.2 16.2 13.3 58.6 7.4
605.1 6,080.7 755.8 67.1 -- 13.8 79.1 5.4
311.6 973.9 1,231.3 29.1 -4.7 4 37.4 1.4
289.6 1,498.9 310.4 31.4 17.4 13.5 46.6 6.1
512.2 8,154.8 829.0 161.5 24.5 30 50 13.9
1,261.4 12,976.8 814.2 173.0 30.1 19 75 13.6

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Clinitech Laboratory

--

  • Incorporated

    2010

  • Chairman

    Jagdish Umakant Nayak

  • Managing Director

    Jagdish Umakant Nayak

  • Headquarters

    Thane, Maharashtra

  • Website

    www.ctllab.in

Edit peer-selector-edit
loading...
loading...

FAQs for Clinitech Laboratory

The share price of Clinitech Laboratory Ltd is ₹40.40 (BSE) as of 21-May-2026 IST. Clinitech Laboratory Ltd has given a return of -5.41% in the last 1 years.

The P/E ratio of Clinitech Laboratory Ltd is 23.36 times as on 21-May-2026, a 58 discount to its peers’ median range of 56.08 times.
The P/B ratio of Clinitech Laboratory Ltd is 1.04 times as on 21-May-2026, a 87 discount to its peers’ median range of 7.78 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
23.27
1.04
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00
2021
0.00
0.00

The 52-week high and low of Clinitech Laboratory Ltd are Rs 57.00 and Rs 28.55 as of 28-May-2026.

Clinitech Laboratory Ltd has a market capitalisation of ₹ 9 Cr as on 21-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Clinitech Laboratory Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.